1. Home
  2. MLYS vs LAND Comparison

MLYS vs LAND Comparison

Compare MLYS & LAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • LAND
  • Stock Information
  • Founded
  • MLYS 2019
  • LAND 1997
  • Country
  • MLYS United States
  • LAND United States
  • Employees
  • MLYS N/A
  • LAND N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • LAND Real Estate Investment Trusts
  • Sector
  • MLYS Health Care
  • LAND Real Estate
  • Exchange
  • MLYS Nasdaq
  • LAND Nasdaq
  • Market Cap
  • MLYS 590.3M
  • LAND 477.4M
  • IPO Year
  • MLYS 2023
  • LAND 2013
  • Fundamental
  • Price
  • MLYS $12.07
  • LAND $11.82
  • Analyst Decision
  • MLYS Strong Buy
  • LAND Strong Buy
  • Analyst Count
  • MLYS 2
  • LAND 4
  • Target Price
  • MLYS $30.00
  • LAND $17.33
  • AVG Volume (30 Days)
  • MLYS 255.3K
  • LAND 248.7K
  • Earning Date
  • MLYS 11-11-2024
  • LAND 11-06-2024
  • Dividend Yield
  • MLYS N/A
  • LAND 4.73%
  • EPS Growth
  • MLYS N/A
  • LAND N/A
  • EPS
  • MLYS N/A
  • LAND N/A
  • Revenue
  • MLYS N/A
  • LAND $88,454,000.00
  • Revenue This Year
  • MLYS N/A
  • LAND N/A
  • Revenue Next Year
  • MLYS N/A
  • LAND $3.31
  • P/E Ratio
  • MLYS N/A
  • LAND N/A
  • Revenue Growth
  • MLYS N/A
  • LAND N/A
  • 52 Week Low
  • MLYS $6.06
  • LAND $11.65
  • 52 Week High
  • MLYS $16.91
  • LAND $15.36
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 41.32
  • LAND 25.71
  • Support Level
  • MLYS $11.30
  • LAND $11.65
  • Resistance Level
  • MLYS $13.06
  • LAND $13.85
  • Average True Range (ATR)
  • MLYS 1.01
  • LAND 0.34
  • MACD
  • MLYS -0.22
  • LAND -0.10
  • Stochastic Oscillator
  • MLYS 14.43
  • LAND 7.73

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About LAND Gladstone Land Corporation

Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment. It is focused on the ownership of high-quality farms and farm-related properties that are leased on a triple-net basis to tenants with a strong operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also own farms that grow certain commodity crops (e.g., corn and beans).

Share on Social Networks: